Reshma Kewalramani - 15 Dec 2023 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
15 Dec 2023
Net transactions value
-$3,858,352
Form type
4
Filing time
19 Dec 2023, 16:15:42 UTC
Previous filing
15 Dec 2023
Next filing
08 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Options Exercise $475,733 +3,058 +2.8% $155.57 111,769 15 Dec 2023 Direct
transaction VRTX Common Stock Options Exercise $2,639,860 +14,077 +13% $187.53 125,846 15 Dec 2023 Direct
transaction VRTX Common Stock Sale $6,973,945 -17,135 -14% $407.00 108,711 15 Dec 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRTX Stock Option (Right to Buy) Options Exercise $0 -3,058 -100% $0.000000* 0 15 Dec 2023 Common Stock 3,058 $155.57 Direct F2
transaction VRTX Stock Option (Right to Buy) Options Exercise $0 -14,077 -90% $0.000000 1,565 15 Dec 2023 Common Stock 14,077 $187.53 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Dr. Kewalramani's company approved trading plan under Rule 10b5-1, which was entered into on 08/11/2023.
F2 Fully vested.